Comprehensive Index of National Vaccine Injury Compensation Program Cases ← all cases Home Firms Attorneys Stats Special Masters About Us

McKinney & Namei Company, L.P.A.

Law Firm · Petitioner Practice VICP Petitioner Practice Last verified
Cases filed
5
Comp rate
40%
Total awarded
$235K
Tenure
2014–2022
Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
McKinney & Namei Company, L.P.A. is a U.S. law firm whose name appears on 5 petitions in the National Vaccine Injury Compensation Program. The firm's filings on file span 2014-2022, with a compensation rate of 40%. Cases on file have produced $235K in total awards. The attorneys appearing on this firm's docket include Firooz Taghi Namei.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Attorneys at this firm (by case volume)
Firooz Taghi Namei5
Most-handled condition categories
Other / multiple2Guillain-Barré Syndrome (GBS)2Encephalitis / encephalopathy1

Frequently asked questions about McKinney & Namei Company, L.P.A.

Answers built from this firm's public case docket.

How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. Research McKinney & Namei Company, L.P.A.'s case history below.
How many VICP cases has McKinney & Namei Company, L.P.A. filed?
McKinney & Namei Company, L.P.A. has filed 5 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2014 and 2022.
What is McKinney & Namei Company, L.P.A.'s compensation rate?
McKinney & Namei Company, L.P.A.'s overall compensation rate across 5 VICP cases is 40% (2 compensated).
How much has McKinney & Namei Company, L.P.A. won in VICP cases?
Cases filed by McKinney & Namei Company, L.P.A. have resulted in $235K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does McKinney & Namei Company, L.P.A. handle?
Based on the cases on file, McKinney & Namei Company, L.P.A.'s practice includes Other / multiple, Guillain-Barré Syndrome (GBS), Encephalitis / encephalopathy, among other vaccine-related conditions.
FiledFinal judgementPetitionerAttorneyFirm Age at VaccinationVaccineCondition OutcomeSpecial MasterAward
2018-10-102022-09-27Pamela A. StrickerFirooz Taghi NameiMcKinney & Namei Company, L.P.A.–influenzaGuillain-Barre Syndrome (GBS)compensatedBrian H. Corcoran$235,138
2012-07-172015-02-09Ronald KeatonFirooz NameiMcKinney & Namei Company, L.P.A.56.0yinfluenzaGuillain-Barre syndrome (GBS) / chronic inflammatory demyelidismissedThomas L. Gowen–
–2014-10-01William J. VoglerFirooz T. NameiMcKinney & Namei Co.; McKinney & Namei Company, L.P.A.33.0yinfluenzameningitisdismissedBrian H. Corcoran–
2012-07-202014-06-20Angela ChavezFirooz Taghi NameiMcKinney & Namei Company–influenza–deniedChristian J. Moran–
2013-01-232014-03-31Kristyn PolenFirooz Taghi NameiMcKinney & Namei Company–HPVfibromyalgia, chronic fatigue, myofascial pain syndrome and compensatedChristian J. Moran–